GABAergic mechanism in the rostral ventrolateral medulla contributes to the hypotension of moxonidine

Cardiovascular Research

Volumn 89, Issue 2, 2011, Pages 473-481

  Peng, Jun Feng ^a   Wu, Zhao Tang ^a   Wang, Yang Kai ^a   Yuan, Wen Jun ^a,b   Sun, Tao ^b   Ni, Xin ^a   Su, Ding Feng ^a   Wang, Wei ^c   Xu, Ming Juan ^d   Wang, Wei Zhong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c NEBRASKA MEDICAL CENTER   (United States)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Centrally antihypertensive drug; Microdialysis; Pre sympathetic neuron; Renal sympathetic nerve activity; Western blot analysis

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; BETA ACTIN; BICUCULLINE; IMIDAZOLINE RECEPTOR; MOXONIDINE;

4 AMINOBUTYRIC ACID RELEASE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG MECHANISM; GABAERGIC SYSTEM; HYPOTENSION; MALE; MICRODIALYSIS; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; ROSTRAL VENTROLATERAL MEDULLA; SYMPATHETIC NERVE; SYMPATHETIC NERVE CELL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOTTING, WESTERN; GABA-A RECEPTOR ANTAGONISTS; GABA-B RECEPTOR ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HEART RATE; HYPOTENSION; IMIDAZOLES; INFUSIONS, INTRAVENTRICULAR; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; KIDNEY; MALE; MEDULLA OBLONGATA; MICRODIALYSIS; MICROINJECTIONS; NEURAL INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RECEPTORS, GABA-B; SYMPATHETIC NERVOUS SYSTEM;

EID: 78751473645     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq289     Document Type: Article

References (45)

1. Haxhiu MA, Dreshaj I, Schafer SG, Ernsberger P. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla. J Cardiovasc Pharmacol 1994;24(Suppl. 1):S1-S8.
2. Ernsberger P, Damon TH, Graff LM, Schafer SG, Christen MO. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites. J Pharmacol Exp Ther 1993;264:172-182.
3. Ernsberger P, Haxhiu MA, Graff LM, Collins LA, Dreshaj I, Grove DL et al. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist. Cardiovasc Drugs Ther 1994;8(Suppl. 1):27-41.
4. Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994;74:323-364.
5. Ernsberger P, Giuliano R, Willette RN, Reis DJ. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther 1990;253:408-418.
6. Gomez RE, Ernsberger P, Feinland G, Reis DJ. Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. Eur J Pharmacol 1991;195:181-191.
7. Granata AR. Effect of moxonidine on putative sympathetic neurons in the rostral ventrolateral medulla of the rat. Neurosignals 2004;13:241-247.
8. Jastrzebski Z, Czyzewska-Szafran H, Gozlinska B, Remiszewska M, Mazurek AP. Clonidine hypotension in spontaneously hypertensive rats (SHR) depends on the functional state of GABAergic and glutamatergic systems. Neurosci Lett 1995;184:94-96.
9. Wang WZ, Wang LG, Gao L, Wang W. Contribution of AMPA/kainate receptors in the rostral ventrolateral medulla to the hypotensive and sympathoinhibitory effects of clonidine. Am J Physiol 2007;293:R1232-R1238.
10. Wang LG, Zeng J, Yuan WJ, Su DF, Wang WZ. Comparative study of NMDA and AMPA/kainate receptors involved in cardiovascular inhibition produced by imidazoline-like drugs in anaesthetized rats. Exp Physiol 2007;92:849-858.
11. Zhang J, Abdel-Rahman AA. The hypotensive action of rilmenidine is dependent on functional N-methyl-D-aspartate receptor in the rostral ventrolateral medulla of conscious spontaneously hypertensive rats. J Pharmacol Exp Ther 2002;303:204-210.
12. Kubo T, Kihara M. Studies on GABAergic mechanisms responsible for cardiovascular regulation in the rostral ventrolateral medulla of the rat. Arch Int Pharmacodyn Ther 1987;285:277-287.
13. Bormann J. The 'ABC' of GABA receptors. Trends Pharmacol Sci 2000;21:16-19.
14. Dampney RA, Horiuchi J, Tagawa T, Fontes MA, Potts PD, Polson JW. Medullary and supramedullary mechanisms regulating sympathetic vasomotor tone. Acta Physiol Scand 2003;177:209-218.
15. Willette RN, Barcas PP, Krieger AJ, Sapru HN. Endogenous GABAergic mechanisms in the medulla and the regulation of blood pressure. J Pharmacol Exp Ther 1984;230: 34-39.
16. Avanzino GL, Ruggeri P, Blanchi D, Cogo CE, Ermirio R, Weaver LC. GABAB receptor-mediated mechanisms in the RVLM studied by microinjections of two GABAB receptor antagonists. Am J Physiol 1994;266:H1722-H1728.
17. Tingley FD III, Arneric SP. Evidence for clonidine presynaptically modulating amino acid release in the rostral ventral medulla: role in hypertension. Brain Res 1990;537: 175-181.
18. Marmo E, Filippelli W, Marrazzo R, Russo S, Cazzola M, Vacca C et al. Participation of GABAergic mechanisms in the hypotensive and bradycardic effects of clonidine: experimental study in conscious normotensive and hypertensive rats. Neuropharmacology 1987;26:1525-1528.
19. Peng J, Wang YK, Wang LG, Yuan WJ, Su DF, Ni X et al. Sympathoinhibitory mechanism of moxonidine: role of the inducible nitric oxide synthase in the rostral ventrolateral medulla. Cardiovasc Res 2009;84:283-291.
20. Wang WZ, Gao L, Wang HJ, Zucker IH, Wang W. Tonic glutamatergic input in the rostral ventrolateral medulla is increased in rats with chronic heart failure. Hypertension 2009;53:370-374.
21. Wang WZ, Yuan WJ, Su DF. Blockade of N-methyl-D-aspartate receptors within the rostral ventrolateral medulla antagonizes clonidine-induced cardiovascular effects. Auton Neurosci 2003;109:21-28.
22. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York, NY: Academic Press; 1998.
23. Chan SH,Wang LL, Chan JY. Differential engagements of glutamate and GABA receptors in cardiovascular actions of endogenous nNOS or iNOS at rostral ventrolateral medulla of rats. Br J Pharmacol 2003;138:584-593.
24. Seagard JL, Hopp FA, Hillard CJ, Dean C. Effects of endocannabinoids on discharge of baroreceptive NTS neurons. Neurosci Lett 2005;381:334-339.
25. Wang J, Peng YJ, Zhu DN. Amino acids modulate the hypotensive effect of angiotensin-(1-7) at the caudal ventrolateral medulla in rats. Regul Pept 2005;129: 1-7.
26. Zhu DN, Moriguchi A, Mikami H, Higaki J, Ogihara T. Central amino acids mediate cardiovascular response to angiotensin II in the rat. Brain Res Bull 1998;45:189-197.
27. Dobrucki LW, Cabrera CL, Bohr DF, Malinski T. Central hypotensive action of clonidine requires nitric oxide. Circulation 2001;104:1884-1886.
28. Moreira TS, Takakura AC, Menani JV, Sato MA, Colombari E. Central blockade of nitric oxide synthesis reduces moxonidine-induced hypotension. Br J Pharmacol 2004;142:765-771.
29. Chan CK, Burke SL, Zhu H, Piletz JE, Head GA. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine. Neuroscience 2005;132:991-1007.
30. Tolentino-Silva FP, Haxhiu MA, Waldbaum S, Dreshaj IA, Ernsberger P. Alpha(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice. Brain Res 2000;862:26-35.
31. Ruggiero DA, Regunathan S,Wang H, Milner TA, Reis DJ. Immunocytochemical localization of an imidazoline receptor protein in the central nervous system. Brain Res 1998;780:270-293.
32. Milner TA, Rosin DL, Lee A, Aicher SA. Alpha2A-adrenergic receptors are primarily presynaptic heteroreceptors in the C1 area of the rat rostral ventrolateral medulla. Brain Res 1999;821:200-211.
33. Hayar A, Guyenet PG. Prototypical imidazoline-1 receptor ligand moxonidine activates alpha2-adrenoceptors in bulbospinal neurons of the RVL. J Neurophysiol 2000; 83:766-776.
34. Sun MK, Reis DJ. GABA-mediated inhibition of pacemaker neurons of rostral ventrolateral medulla by clonidine in vitro. Eur J Pharmacol 1995;276:291-296.
35. Foley CM, Stanton JJ, Price EM, Cunningham JT, Hasser EM, Heesch CM. GABA(A) alpha1 and alpha2 receptor subunit expression in rostral ventrolateral medulla in nonpregnant and pregnant rats. Brain Res 2003;975:196-206.
36. Bowery NG, Hudson AL, Price GW. GABAA and GABAB receptor site distribution in the rat central nervous system. Neuroscience 1987;20:365-383.
37. Hill DR, Bowery NG. 3H-baclofen and 3H-GABA bind to bicuculline- insensitive GABA B sites in rat brain. Nature 1981;290:149-152.
38. Szabo B. Imidazoline antihypertensive drugs: a critical review on their mechanism of action. Pharmacol Ther 2002;93:1-35.
39. Guyenet PG. Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites? Am J Physiol 1997;273:R1580-R1584.
40. Stevens CF. Neurotransmitter release at central synapses. Neuron 2003;40:381-388.
41. Santos MS, Goncalves PP, Carvalho AP. Effect of ouabain on the gamma-[3 H]aminobutyric acid uptake and release in the absence of Ca(+)+ and K(+)- depolarization. J Pharmacol Exp Ther 1990;253:620-627.
42. Molderings GJ, Bonisch H, Bruss M, Wolf C, von Kügelgen I, Gothert M. S1P-receptors in PC12 and transfected HEK293 cells: molecular targets of hypotensive imidazoline I(1) receptor ligands. Neurochem Int 2007;51: 476-485.
43. Zanelli S, Naylor M, Kapur J. Nitric oxide alters GABAergic synaptic transmission in cultured hippocampal neurons. Brain Res 2009;1297:23-31.
44. Giovannini MG, Mutolo D, Bianchi L, Michelassi A, Pepeu G. NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study. J Neurosci 1994;14:1358-1365.
45. Perouansky M, Grantyn R. Mechanisms of excitatory amino acid-induced stimulation of GABAergic synaptic activity in cultures from the rat superior colliculus. Adv Exp Med Biol 1990;268:229-238.